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Abstract We report the characterization of three novel mem- 
bers of the KRAB-domain-containing C2-H~ zinc finger family 
(ZNFI33, 136 and 140). KRAB (Kriippel-associated box) is an 
evolutionarily conserved protein domain found N-terminally with 
respect o the zinc finger repeats that encodes the DNA binding 
domain. ZNF133 and ZNF140 have both the KRAB A- and 
KRAB B-boxes present at their N-terminus, whereas ZNF136 
contains only the KRAB A-box. We have previously demon- 
strated that the KRAB domains derived from ZNF133 and 
ZNF140 are potent transcriptional repression domains [Margolin 
et al. (1994) Proc. Natl. Acad. Sci. USA 91, 4509-4513]. The 
KRAB domain from ZNF136, containing only subdomain A, is 
a considerable weaker suppression domain; however, when fused 
to the heteroiogous KRAB B subdomain of ZNF10 (KOX1) the 
two subdomains form a KRAB domain which induces repression 
as potently as previously reported KRAB domains. 
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1. Introduction 
Differential regulation of gene expression in eukaryotes i
mediated in part by specific binding of transcription factors to 
DNA sequences. DNA binding proteins can be classified ac- 
cording to the conserved structural motifs they have in com- 
mon and more than 10 families with distinct DNA binding 
motifs have been identified [1]. One such motif is the C2 H2 (or 
K@pel) type zinc finger repeat first described in Xenopus tran- 
scription factor IIIA (TFIIIA) [2]. Since then this motif has 
been found in many proteins with transcriptional regulatory 
functions e.g., in transcription factor Spl and yeast regulatory 
gene GAL4, in the Drosophila Kriippel and hunchback segmen- 
tation genes [3,4], in the Wilms' tumor (WT1) supressor gene 
[5] and in Gli-3 which is implicated in Grieg syndrome [6]. 
Zinc finger proteins (ZFPs) of the C2-H2 type consist of 
tandem arrays of two or more zinc fingers. The basic structural 
unit is composed of typically 28-30 amino acids with a consen- 
sus sequence of CX24CX3FXsLX2HX34H (X is any amino 
acid), where the two pairs of cysteines and histidines tetrahe- 
drally coordinate a zinc ion [2]. Each repeated finger unit is 
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separated by the highly conserved stretch of 7 amino acids 
TGEKPYX (H/C link) which extends from the last histidine of 
one finger unit to the first cysteine of the next unit [7] and may 
play a role in aligning the finger domains within the major 
grove of the DNA helix [8]. The H/C link consensus sequence 
has been used to isolate C: H2 type zinc finger genes from 
Xenopus [9], mouse [10], and human [11,12]. 
It has been estimated that there are 300700 different ZFP 
genes in the human genome [11], and similarly high numbers 
have been found in Xenopus [13] and mouse [14]. Many ZFP 
genes are clustered within the human genome and zinc finger 
loci have been found to reside predominantly either in telomeric 
regions or in chromosomal bands known to exibit chromosome 
fragility [15 17]. Chromosome 19 carries a disproportionate 
fraction of the zinc finger genes mapped so far, in particular, 
a gene complex containing over 40 genes has been identified in 
chromosomal region 19p 12-p 13.1 [18]. This cluster consists of 
KRAB (Kriippel-associated box) zinc finger proteins (KRAB- 
ZFPs) that constitutes a subfamily of up to one third of the 
C 2 H 2 type ZFPs [19]. The KRAB domain is an evolutionarily 
conserved omain of about 75 amino acids found N-terminal 
with respect o the finger domain, and is composed of two 
contiguous modules: KRAB A- and K RAB B-box [19-22]. The 
KRAB-ZFPs exibit a common exon/intron organization with 
the variant zinc finger repeats present in a single exon and the 
KRAB-A and -B domain encoded by separate xons [18,21]. 
The exon/intron structure suggests that isoforms of KRAB- 
ZFPs with the domain absent or partially deleted could arise 
by alternative splicing, thus increasing the number of distinct 
expressed ZFPs. 
We have previously characterized a KRAB-ZF P (ZN F 141 ) 
that maps within the minimal chromosomal region for the 
Wol~Hirschhorn syndrome (WHS) at 4p16.3 [23], and have 
demonstrated that the KRAB domain from ZNF141 is a potent 
transciptional repressor [24]. Here we report the isolation and 
functional characterization f three additional KRAB-ZFPs 
and show that independent KRAB A and B subdomains can 
be fused to generate a functional KRAB domain with enhanced 
repressor actixity in comparison to subdomains alone. 
2. Materials and methods 
2.1. Construction and screening o/eDNA library 
Total RNA was isolated [25] from a human insulinoma and enriched 
for mRNA by oligo-(dT) cellulose chromatography [26]. A cDNA 
plasmid library was constructed from 5/~g mRNA essentially asprevi- 
ously described [27]. After BstXI linker (Invitrogen, San Diego, CA) 
addition to the double stranded cDNA. a size fractionation was per- 
formed on an 0.8% agarose gel to generate wo size classes of eDNA: 
0.5 to 2 kb and 2 to 10 kb. The eDNA was electroeluted in a dialysis 
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bag and purified by phenol and chloroform extractions prior to ethanol 
precipitation. 
A modified cDNA cloning vector, pLN86, was constructed from the 
pVEGT' plasmid [27] by expanding the multiple cloning site with a 
BstX! recognition site, and the size selected cDNA fractions were li- 
gated into this vector and electrotransformed into ElectroMAX 
DH10B cells (Life Technologies, Gaithersburg, MD) as described by 
the supplier. The fraction of the cDNA library with the longer inserts 
contained 0.2 x 10 6 clones. Upon plating on LB-agar plates, the colo- 
nies were washed off the plates (approximately 10,000 colonies/ml LB- 
broth, 15% glycerol) and frozen at -80°C for storage. 
The high molecular weight library was plated on nitrocellulose filters 
(Schleicher and Schuell, Dassel, Germany) and hybridized to a radiola- 
belled degenerate oligonucleotide CA(CT)AC(AG)GG(AGT)- 
GA(AG)CC(ACT)TA recognizing the HTGEKPY linker region of the 
C2 H2 type zinc finger. The hybridization was done at 37°C overnight 
in 6x SSC, 1% SDS, 10x Denhardt, 10 mM EDTA, 150/lg/ml poly A, 
50/tg yeast RNA. The filters were washed 3 times in 6x SSC at 44°C 
before exposure. One hundred positive colonies were isolated from 
which 20 were randomly selected. Plasmid DNA was prepared using 
Qiagen columns (Qiagen Inc., Chatsworth, CA) for further analysis. 
2.2. DNA sequencing and analysis 
Primer walking DNA sequencing was performed on an A.L.F. se- 
quencer (Pharmacia, Uppsala, Sweden) using fluorescein labelled se- 
quencing primers ynthesized on a 394 Applied Biosystem DNA syn- 
thesizer (Applied Biosystems, Foster City, CA). Sequence reactions 
were carried out using the AutoRead Sequence Kit (Pharmacia, 
Uppsala, Sweden) according to the supplier. Sequences were compiled 
and analysed using the Sequence Analysis Software Package (version 
7) from the Wisconsin Genetic Computer Group. 
2.3. Reporter vectors for mammalian cells' 
The modified luciferase containing plasmids were derived from 
pGL2-Control (Stratagene), in which the luciferase gene is driven by 
SV40 enhancer and SV40 promoter elements. In the plasmid 5'- 
GAL4(+) pGL2-Control, 5 synthetic GAL4 DNA binding sites were 
cloned in clockwise orientation i  the BamHI restriction site at nucleo- 
tide position 37. 
2.4. Expression vectors 
Construction of the GAL4-containing fusion genes were performed 
using the expession plasmids pMl and pM2 [28]. This plasmid contains 
the SV40 early promoter and origin of replication, driving expression 
of the DNA binding domain of GAL4 (1 147). A polylinker inserted 
into the gene encoding the carboxy terminus of GAL4 (1 147) allows 
in-frame cloning and expression of GAL4 fusion proteins. Plasmids 
containing GAL4-ZNF10, -ZNFI33, -ZNFI40, -ZNF141 have previ- 
ously been described [24]. The GAL4 expression plasmid pM 1 encoding 
the KRAB A subdomain of ZNF136, and pM2 encoding the KRAB 
B subdomain of ZNF10 (KOX1), were constructed via polymerase 
chain reaction (PCR) amplification of the desired NH:-terminal 
KRAB-containing regions using synthetic oligonucleotide primers. The 
5' PCR primers contained BglII restriction sites (5' AATACAGATC- 
TATGGACTCGGTGGCTTTTGAG for ZNFI36; 5' TAAAGATC- 
TGGTTATCAGCTTACTAAGCC for ZNF10) and the 3' PCR prim- 
ers contained a BamHI site (5' TCAATGGATCCGGGATTTTCTT- 
GCTCAGATTCTGA for ZNF136; 5' TCAATGGATCCAAATGC- 
AGTCTCTGAATCAGG). Standard PCR reactions using Pfu polym- 
erase (Stratagene) were performed using the indicated zinc finger 
cDNAs as templates. The PCR fragments were isolated from a 6% 
polyacrylamide gel, cloned and sequenced. 
The chimeric KRAB domain between the A subdomain of ZNFI36 
and the B subdomain of ZNF 10 was constructed by making use of PCR 
based site directed mutagenesis [29]. Two PCR reactions were run, one 
with the cDNA of ZNF136, the other with the cDNA of ZNF10. The 
PCR sample of ZNF136 included the 5' primer (5' AATACAGATC- 
TATGGACTCGGTGGCTTTTGAG) that contained a BglII site and 
the 3' primer (5' GATAACCCTATAGAGGCCAGATTC) that is 
complementary at the 5' end to the 5' primer of the B subdomain. The 
PCR reaction mix of ZNF10 had a 5' primer (5' TCAATGGATCC- 
AAATGCAGTCTCTGAATCAGG) complementary at the 5' end to 
the 3' primer of ZNFI36. The 3' primer (5' CTGGCCTCTATAGG- 
GTTATCAGCTTACTAAG) contained a BamHl site. The complete 
hybrid fragment was generated by performing a second PCR using the 
5' primer of ZNF136 and the 3' primer of ZNF10. The PCR product 
was extracted with phenol/chloroform, digested with BamHI and BglII, 
gel purified and cloned into the BamHI site of pM1 to generate pG- 
hybrid. 
Each fusion protein contained GAL4 (1 147) [30], followed by argin- 
ine, asparagine, glycine, serine and the indicated segment of the 
cDNAs. The methionine encoded at nt 71 in the ZNF10 cDNA [12] was 
designated as aa 1 for the ZNF10 containing constructs. The segments 
of the other cDNAs were similarly designated with the first in-frame 
encoded methionine named aa 1. The cDNAs were fused to GAL4 as 
follows: ZNF10 nt 71 343 (aa 1 91), nt 232-343 (aa 54-91), nt 71 229 
(aa 1 53); ZNF133, nt 449-.909 (aa 1 119); ZNF136, nt 72 359 (aa 
1 96); ZNF140, nt 273-590 (aa 1 106); ZNF141, nt 157 591 (aa 1 145); 
ZNFI36/ZNF10, nt 72 272/232--343 (aa 1 67154-91). Sequences of all 
PCR derived constructs were verified by sequence analysis. The stable 
expression of chimeric GAL4 fusion protein was confirmed [24]. 
2.5. Liposome-mediated transfection 
5 × 105 1 × 10 6 exponentially growing HeLa cells were plated in a 100 
mm culture dish and grown in a CO2 incubator at 37°C to 80% conflu- 
ence. The cells were then transfected by using LIPOFECTIN reagent 
following the manufacturers protocol (Gibco-BRL, Gaithersburg, MD, 
USA). Each dish of sub-confluent HeLa cells received 5/~g reporter 
plasmid, 5/ lg expression plasmid and 2/~g of the fl-D-galactosidase 
expression plasmid pON260 [31]. 48 72 h after transfection fl-D-galac- 
tosidase and luciferase activity were determined from the cell extract, 
The fl-D-galactosidase activity was used to to normalize the luciferase 
activity. Each transfection experiment was performed in duplicate three 
to four times, using at least three different preparations of plasmid 
DNA. The variation among expreriments was 10 20%. There was no 
overall toxic effects (measured by reduction in cell number or fl-t)- 
galactosidase activity) as a result of expressing the GAL4 fusions in 
transient assays which could account for the repression observed. 
2.6. Extraction of cells 
Cells (1 3 × 106 cells) were collected 2448 h after transfection and 
washed twice with PBS and lysed in 200 ,ul cell extract buffer [32]. 
Supernatants were obtained by centrifugation and frozen at -20°C. 
Protein content of the extracts were determined according to Bradford 
[33]. 
2. 7. LuciJerase assay 
350/tl luciferace assay buffer [34] was mixed with 10/A extract and 
the luciferase activity was determined in a Lumat LB9501 (Berthold, 
Wildbad, Germany) using intergral mode (10 s at 25°C). D-Luciferin 
was used at 1 mM. 
3. Results 
3.1. Isolation and sequencing analysis of  KRAB-ZNFs  
Zinc finger proteins of the C2-H 2 type usually have conserved 
sequences with the TGEKPYX mot i f  separating the tandemly 
arranged finger domains [11]. A degenerate oligonucleotide 
probe from this region was used to identify cDNAs with C2 Hz- 
type finger domains from a human insul inoma cDNA library. 
Approximately one hundred positive clones were identified 
from which twenty were selected randomly for further analysis. 
Sequence analysis revealed that four cDNA clones belong to 
a subfamily, since in addit ion to the finger domain they contain 
a conserved N-terminal KRAB domain [19]. The characterisa- 
tion of one of the cDNAs, ZNF141, has previously been re- 
ported [23]. The complete nucleotide sequence of the other 
cDNAs have been deposited in Genbank  with the accession 
numbers, ZNF I33:  U09366, ZNF136: U09367, and ZNF140: 
U09368.  The predicted amino acid sequences of the zinc finger 
domains in all three ZNFs  conform to the general pattern 
CXzCXI2HXsH preceeded by a conserved seven amino acid 
H/C link. ZNF133 contains an open reading frame of 1620 
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Fig. 1. Comparison of N-terminal KRAB domains from ZNF136, ZNFI33. ZNFI40, ZNFI41 [23], and ZNFI0[12]. Highly conserved amino acids 
are in bold and below is shown the derived consensus sequence l¥om the five KRAB A domains and the tbur KRAB B donmins. 
nucleotides that encodes 13 contiguous zinc finger domains. 
The sequence preceeding finger 1 is most likely a degenerate 
finger, since the amino acid at position 142 is a arginine instead 
of the predicted cysteine and thus will have destroyed the puta- 
tive binding capacity. The first 65 amino acids defines the A- 
and B-box of a KRAB domain with strong homology to those 
previously characterised (Fig. 1). The predicted molecular 
weight of the ZNF133 protein is 62.7 kDa. The cDNA contains 
part of a repetitive ALU element in the 3' untranslated region 
from nucleotide 2372. A second cDNA, ZN F 133a, was isolated 
which has an identical open reading frame as ZNFI33 except 
at position 662, where the trinucleotide GCA encoding alan- 
ine 74 in the juntion between the KRAB B subdomain and the 
finger domain is deleted. The 5' untranslated region of 
ZNF133a extends more than 1 kb and is different from 
ZNF133 (data not shown). The nucleotide sequence of ZNF140 
predicts a protein of 457 amino acids with 10 contiguous zinc 
finger domains and a KRAB domain at the N-terminus (Fig. 
1). The predicted molecular weight of ZNF140 is 52.0 kDa. 
ZNFI36 encodes 14 contiguous zinc finger domains followed 
by one degenerate finger in which the last histidine at position 
628 is replaced by a threonine (Fig. 2) and is therefore not 
expected participate in DNA binding. The KRAB domain in 
ZNF136 has only the A-box present (Fig. 1) at the N-terminal 
end. The predicted molecular weight of the protein is 73.4 kDa. 
Comparison of different KRAB AB and KRAB A domains 
3000 
The first 300 base pairs of the eDNA is a repetitive ALU 
element. Multiple alignment of the three ZNFs peptide se- 
quences reveals a40-46% identity (50 55% nucleotide identity), 
whereas the KRAB A peptide domains are 50 70% identical. 
Northern blot analysis revealed an apparently ubiquitous ex- 
pression pattern of all three ZNFs (expressed in heart, brain, 
placenta, lung, liver, skeletal muscle, kidney, pancreas data 
not shown). 
3.2. The KRAB domain ¢~/ZNF136 is' a weak repressor 
The N-terminal KRAB domains were fused to the GAL4 
DNA binding domain and assayed quantitatively for transcip- 
tional repressor activity using the luciferase reporter gene 
driven by the SV40 promotor in HeLa cells (Fig. 2A). The 
KRAB domains from ZNF133, ZNF 140 and ZNF10 [12] in- 
duce almost complete repression in comparison with GAL4 
pG(1 174) ahme, as previously described [24]. However, the 
KRAB domain from ZNF136 encoding the A-box alone only 
represses the activity to about 30 percent. A similar activity is 
observed by fusing the A-box from ZNFI0 to GAL4 (ZNFI0- 
A). 
3.3. The KRAB B subdomain ~/' KOX1 enhances the repressor 
activity ~?/' KRAB A subch~main ~/  ZNF l36  
In order to asses whether heterologous KRAB A and B 
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Fig. 2. Transcriptional repression by KRAB domains fused to the GAL4 protein. Transcriptional repressor activity was assayed with the luciferase 
reporter gene driven by the SV40 early promoter in the HeLa cells. (A) Comparison of different KRAB AB and KRAB A domains. (B) Repression 
analysis of heterologous KRAB domains. 
156 H. Vissing et al. IFEBS Letters 369 (1995) 153 157 
subdomains are synergistic in their transcriptional repression 
or are only active in conjunction with their native associated 
subdomains, the B subdomain from ZNF10 and the KRAB 
domain of ZNF136 were fused to GAL4 (pG-hydrid). The 
introduction of a heterologous B subdomain to ZNF136 en- 
hances the repressor activity to similar levels as seen with 
ZNF133, ZNF 140 and the native ZNF10 (Fig. 2B). The ZNFI0 
KRAB B subdomain alone does not induce significant repres- 
sion when compared to ZNF136 or ZNF10-A. 
4. Discussion 
Out of twenty randomly selected ZNF cDNAs we identified 
four novel ZNFs with KRAB domains in the N-terminal part 
of the predicted peptide. This finding corroborates the notion 
that a large fraction of ZNFs in the genome contains the highly 
conserved KRAB domains [19]. It has previously been shown 
that a subfamily of KRAB-ZNF genes has an clustered organ- 
ization in the genome on chromosome s gment 19p12 [18]. The 
KRAB-ZNFs presented here and ZNF141 map at different 
locations (ZNF133 - 20p11.2; ZNF136 - 19q13.1; ZNF140 - 
12q34.33; ZNF141 - 4p16.3) [23,35] indicating a wide distribu- 
tion of KRAB-ZNF genes in the genome. Whether these 
KRAB-ZNF genes are part of different gene clusters that are 
structuraly related is not known. Despite a wide distribution 
in the genome the KRAB-ZNFs conform to the stringent 
CX2CXlzHX3HX 7 finger motif with up to 50% conserved 
amino acid sequence in the zinc finger domain and up to 70% 
in the KRAB domain. 
The KRAB domains from different ZNFs are potent ran- 
scriptional repressors when fused to the GAL4 DNA binding 
domain [24,36,37], and it has been shown that the KRAB A 
subdomain is sufficient for the induction of transciptional re- 
pression. However, when the repression is measured quantita- 
tively the KRAB A subdomain alone (ZNF136) is a much 
weaker repressor than the entire KRAB domain (ZNF10, 
ZNF133, ZNF140 and ZNF141). The question arises whether 
the KRAB domains only induce complete repression with their 
native encoded subdomains or whether there is a synergistic 
effect when heterologous subdomains are fused together. To 
investigate this, the KRAB B subdomain from ZNF10 was 
added to the KRAB domain from ZNF136 (which only con- 
tains the A subdomain) and fused to GAL4 DNA binding 
domain. The introduction of a heterologous B subdomain to 
ZNF136 enhances the repressor activity to similar levels as is 
seen with ZNF133, ZNF140, ZNF141 and ZNF10 native 
KRAB domains. The KRAB B subdomain from ZNF10 does 
not alone induce significant repression demonstrating that the 
observed activity seen with ZNF136-ZNF10-B is not a simple 
additive ffect from two independent A and B subdomains. 
Immunoprecipitation of stably expressed ZNF 10 KRAB do- 
mains fused to the tetracycline r pressor revealed the associa- 
tion of an endogenous protein to the KRAB domain of ZNF 10 
[34]. This protein designated SMP1 (Silencing Mediating Pro- 
tein 1) is approximately 110 kDa. It has been emphasized that 
SMP 1 might constitue a putative co-repressor that mediates the 
repression activity employed by the KRAB domain of any 
KRAB containing zinc finger protein. In this respect, further 
investigations are in progress to clarify whether SMP1 binds to 
the other characterized KRAB domains. It seems likely that the 
KRAB A versus the KRAB AB domains have varying re- 
pressor activities due to altered affinities between SMP1 and 
the KRAB domains. Alternatively, the repression could be 
mediated by additional co-repressor p oteins that bind predom- 
inatly to the KRAB B subdomain. 
So far, a KRAB B subdomain has not yet been identified in 
the genomic region of ZNF136. It has not yet been demon- 
strated that genomic zinc finger genes encoding both KRAB 
subdomains can express altered NH2-terminal modified KRAB 
domains with different repressor activities. However, our anal- 
ysis of differential repressor activities of KRAB A versus 
KRAB AB domains points in this direction. 
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